News
Ozempic is massively threatening the established diet industry — and it appears that Weight Watchers is now getting the ...
Our attraction to sugar has grown to an unhealthy level. The average person in the United States now consumes more than 100 ...
For patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis, semaglutide is associated with improved liver histologic outcomes.
With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
Yet, despite more than 20 years of study, the sweet receptor’s precise architecture remained elusive, even as scientists ...
Over time, scar tissue slows or stops implanted bioelectronics. But new interdisciplinary research could help pacemakers, ...
Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...
The NSF has awarded a Faculty Early Career Development Program grant to Jing Li, assistant professor of medical chemistry and ...
Stealthy, subtle facelifts are on the rise, and it’s not just celebrities who are going under the knife. Katie Rosseinsky ...
Semaglutide - the active ingredient in medications like Ozempic and WeGovy - is only FDA approved for Type-2 diabetes, but ...
Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results